Some of the nation’s largest pharmaceutical companies have dramatically reduced payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a ProPublica analysis shows. Aaron Kesselheim, assistant professor of medicine at Brigham and Women’s Hospital, is quoted.
